Correction: Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Wimmer K, Hlauschek D, Balic M, Pfeiler G, Greil R, Singer CF, Halper S, Steger G, Suppan C, Gampenrieder SP, Helfgott R, Egle D, Filipits M, Jakesz R, Sölkner L, Fesl C, Gnant M, Fitzal F.
Wimmer K, et al. Among authors: singer cf.
Breast Cancer Res Treat. 2024 May 5. doi: 10.1007/s10549-024-07351-5. Online ahead of print.
Breast Cancer Res Treat. 2024.
PMID: 38704775
No abstract available.